Literature DB >> 1194854

Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice.

H A Freedman, F Lilly, R A Steeves.   

Abstract

BALB/c-H-2b (BALB.B) mice are less susceptible to the Friend virus (FV) disease syndrome than congenic BALB/c (H-2d) mice, and spleen cells from FV-infected BALB.B mice are markedly less tumorigenic on transplantation to syngeneic hosts than those from FV-infected BALB/c mice. For these reasons we investigated the expression of FV-associated cell surface antigens on cultured, FV-trnasformed cell lines of BALB.B and BALB/c origin. Both cell lines induced transplantation immunity in syngeneic hosts toward further implantations of the same tumor, BALB.B cells being significantly more potent in this respect than BALB/c cells. BALB.B tumor cells, which produce complete, infectious FV, expressed both the cell surface antigen, FMR (corresponding to the cytotoxic antibodies in anti-FV antisera), and virus envelope antigen (VEA, corresponding to the virus-neutralizing antibodies in the anti-FV antisera). BALB/c tumor cells, on the other hand, which are FV-nonproducers, expressed no FMR antigen, but did express VEA on their surfaces for at least 100 passages in culture. These cells could induce FV-neutralizing but not cytotoxic anti-FMR antibodies when used to immunize syngeneic hosts. The absence of FMR antigen may be the basis for the reduced capacity of BALB/c tumor cells, by comparison with BALB.B tumor cells, to induce transplantation immunity. After about the 125th serial transfer in culture, BALB/c tumor cells spontaneously ceased to express VEA and simultaneously became very weak inducers of transplantation immunity in BALB/c hosts. This loss of VEA did not stem from the loss of either the spleen focus-forming virus or the helper virus genomes from these cells, since both viruses could still be recovered from the cell line.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1194854      PMCID: PMC2190061          DOI: 10.1084/jem.142.6.1365

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Studies on the FMR antigen.

Authors:  F Lilly; S G Nathenson
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

2.  Rapid assay of murine leukemia virus helper activity for Friend spleen focus-forming virus.

Authors:  R A Steeves; R J Eckner; E A Mirand; R L Priore
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

3.  Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex.

Authors:  R A Steeves; R J Eckner; M Bennett; E A Mirand; P J Trudel
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

Review 4.  Antigens of murine leukemia viruses.

Authors:  F Lilly; R Steeves
Journal:  Biochim Biophys Acta       Date:  1974-04-29

Review 5.  Antigens of tumors and leukemias induced by viruses.

Authors:  L J Old; E A Boyse
Journal:  Fed Proc       Date:  1965 Sep-Oct

6.  Cell surface antigen induced by Friend murine leukemia virus is also in the virion.

Authors:  M Friedman; F Lilly; S G Nathenson
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

7.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

8.  A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera.

Authors:  R J Eckner; R A Steeves
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

9.  A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses.

Authors:  T Pincus; J W Hartley; W P Rowe
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

10.  Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice.

Authors:  H A Freedman; F Lilly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  6 in total

1.  Mutations in the env gene of friend spleen focus-forming virus overcome Fv-2r-mediated resistance to Friend virus-induced erythroleukemia.

Authors:  M K Majumdar; C L Cho; M T Fox; K L Eckner; S Kozak; D Kabat; R W Geib
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Viral protein expression in producer and nonproducer clones of friend erythroleukemia cell lines.

Authors:  R Anand; F Lilly; S Ruscetti
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

3.  Identification of an FMR cell surface antigen associated with murine leukemia virus-infected cells.

Authors:  R C Nowinski; S Emery; J Ledbetter
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

4.  Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes.

Authors:  J M Chapdelaine; F Plata; F Lilly
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

5.  Immunological T-cell memory in the in vitro-induced experimental autoimmune orchitis: specificity of the reaction and tissue distribution of the autoantigens.

Authors:  H Wekerle
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

6.  In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.

Authors:  S Gillis; K A Smith
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.